Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News RVL Pharmaceuticals PLC (EM) RVLPQ

Healthcare Biotechnology
RVL Pharmaceuticals plc operates as a specialty pharmaceutical company. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic... see more

Current News (EXPM:RVLPQ)

RVL Completes Financial Restructuring

GlobeNewswire November 27, 2023

RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries

GlobeNewswire October 12, 2023

RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire August 23, 2023

RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

GlobeNewswire August 16, 2023

RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review

GlobeNewswire August 14, 2023

RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update

GlobeNewswire August 2, 2023

RVL Pharmaceuticals plc Provides Business Update

GlobeNewswire July 5, 2023

RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting

GlobeNewswire June 15, 2023

RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update

GlobeNewswire May 11, 2023
View More News ››

Opinion & Analysis (EXPM:RVLPQ)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:RVLPQ)

Be the first to post on this bullboard.

Grizzly Discoveries Inc

Grizzly Discoveries Inc

Grizzly Discoveries Inc. engages in the acquisition, exploration, and development of precious and base metals properties ...
View More »

Podcasts